ID   DH B-LCL
AC   CVCL_C5VU
DR   Wikidata; Q116048831
RX   PubMed=10843661;
CC   HLA typing: A*02,11; B*27:04,40 (PubMed=10843661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
RX   PubMed=10843661; DOI=10.4049/jimmunol.164.12.6120;
RA   Crotzer, Victoria L.
RA   Christian, Robert E.
RA   Brooks, Jill M.
RA   Shabanowitz, Jeffrey
RA   Settlage, Robert E.
RA   Marto, Jarrod A.
RA   White, Forest M.
RA   Rickinson, Alan Bernard
RA   Hunt, Donald Frederick
RA   Engelhard, Victor H.
RT   "Immunodominance among EBV-derived epitopes restricted by HLA-B27 does
RT   not correlate with epitope abundance in EBV-transformed
RT   B-lymphoblastoid cell lines.";
RL   J. Immunol. 164:6120-6129(2000).
//